Difference between revisions of "Part:BBa K4165157"
Line 3: | Line 3: | ||
<partinfo>BBa_K4165157 short</partinfo> | <partinfo>BBa_K4165157 short</partinfo> | ||
− | + | A synthetic peptide that is used for targeting misfolded tau protein (BBa_K4165009) as it binds to PHF6 of tau fibrils. | |
===Usage and Biology=== | ===Usage and Biology=== | ||
− | MMDP2 peptide sequence is HSDLWRRSFELM, it binds to <sup>275</sup>-VQIINK-<sup>280</sup> (PHF*) and <sup>306</sup>-VQIVYK-<sup>311</sup> (PHF) motifs of tau that are reported to drive tau paired helical filament aggregates | + | MMDP2 peptide sequence is HSDLWRRSFELM, it binds to <sup>275</sup>-VQIINK-<sup>280</sup> (PHF*) and <sup>306</sup>-VQIVYK-<sup>311</sup> (PHF) motifs of tau that are reported to drive tau paired helical filament aggregates, it inhibits formation of PHF* aggregates, but not PHF and full-length tau driven aggregates. |
<span class='h3bb'> <p style=" font-weight: bold; font-size:17px;"> Sequence and Features</p> </span> | <span class='h3bb'> <p style=" font-weight: bold; font-size:17px;"> Sequence and Features</p> </span> | ||
Line 20: | Line 20: | ||
<html> | <html> | ||
− | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/mmdp6.png" style="margin-left: | + | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/mmdp6.png" style="margin-left:300px;" alt="" width="300" /></p> |
</html> | </html> | ||
Line 30: | Line 30: | ||
<html> | <html> | ||
− | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/mmdp6-qa.png" style="margin-left: | + | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/mmdp6-qa.png" style="margin-left:50px;" alt="" width="800" /></p> |
</html> | </html> | ||
<!-- --> | <!-- --> |
Latest revision as of 14:58, 11 October 2022
MMDP6 Peptide
A synthetic peptide that is used for targeting misfolded tau protein (BBa_K4165009) as it binds to PHF6 of tau fibrils.
Usage and Biology
MMDP2 peptide sequence is HSDLWRRSFELM, it binds to 275-VQIINK-280 (PHF*) and 306-VQIVYK-311 (PHF) motifs of tau that are reported to drive tau paired helical filament aggregates, it inhibits formation of PHF* aggregates, but not PHF and full-length tau driven aggregates.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Dry Lab
Modeling
MMDP6 is modeled by AlphaFold2 and Apptest, best model obtained from AlphaFold2
Figure 1.: Predicted 3D structure of Synthetic peptide MMDP6.
Table 1: Quality assessment parameters of MMDP6 model.
References
1. Malhis, M., Kaniyappan, S., Aillaud, I., Chandupatla, R. R., Ramirez, L. M., Zweckstetter, M., ... & Funke, S. A. (2021). Potent Tau Aggregation Inhibitor D‐Peptides Selected against Tau‐Repeat 2 Using Mirror Image Phage Display. ChemBioChem, 22(21), 3049-3059.